SYNOKEMS
Windlas Biotech's financials a tad weaker than peers but prospects strongWBL is rolling out a Rs 402-crore IPO comprising Rs 165 crore of fresh issue and an offer-for-sale in which one of the promoters is selling...03 Aug, 2021, 09.30 AM IST
NPPA fixes retail prices of 14 formulationsDrug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products.02 Jan, 2018, 04.45 PM IST
Load More